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Abstract
Human T-cell Immunoglobulin and Mucin-domain containing proteins (TIM1, 3, and 4) specifically bind phosphatidylserine
(PS). TIM1 has been proposed to serve as a cellular receptor for hepatitis A virus and Ebola virus and as an entry factor for
dengue virus. Here we show that TIM1 promotes infection of retroviruses and virus-like particles (VLPs) pseudotyped with a
range of viral entry proteins, in particular those from the filovirus, flavivirus, New World arenavirus and alphavirus families.
TIM1 also robustly enhanced the infection of replication-competent viruses from the same families, including dengue,
Tacaribe, Sindbis and Ross River viruses. All interactions between TIM1 and pseudoviruses or VLPs were PS-mediated, as
demonstrated with liposome blocking and TIM1 mutagenesis experiments. In addition, other PS-binding proteins, such as
Axl and TIM4, promoted infection similarly to TIM1. Finally, the blocking of PS receptors on macrophages inhibited the entry
of Ebola VLPs, suggesting that PS receptors can contribute to infection in physiologically relevant cells. Notably, infection
mediated by the entry proteins of Lassa fever virus, influenza A virus and SARS coronavirus was largely unaffected by TIM1
expression. Taken together our data show that TIM1 and related PS-binding proteins promote infection of diverse families
of enveloped viruses, and may therefore be useful targets for broad-spectrum antiviral therapies.
Citation: Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, et al. (2013) TIM-family Proteins Promote Infection of Multiple Enveloped Viruses through Virion-
associated Phosphatidylserine. PLoS Pathog 9(3): e1003232. doi:10.1371/journal.ppat.1003232
Editor: Theodore C. Pierson, National Institutes of Health, United States of America
Received May 16, 2012; Accepted January 23, 2013; Published March 28, 2013
Copyright:  2013 Jemielity et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was supported by NIH grants AI074879 to HC, AI057159 to HC and MF and AI054456 and AI089955 to GJF, DTU and RHD (http://www.nih.
gov). SJ was supported by a fellowship from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hchoe@scripps.edu
¤ Current address: Department of Infectious Diseases, The Scripps Research Institute, Jupiter, Florida, United States of America
Introduction
The entry of enveloped viruses is a multi-stage process.
Following attachment, some viruses fuse to cells at the plasma
membrane, whereas others are internalized through various
endocytic routes and, primed by low pH or compartment-resident
factors, fuse at the endo/lysosomal membranes. Viruses attach to
the cell surface through the binding of their entry glycoproteins
(GPs) to specific receptors/coreceptors and also through less
specific interactions with various attachment factors [1]. While the
distinction between attachment factors and bona fide receptors has
not always been carefully made, receptors typically involve
necessary, specific, and high-affinity interactions that can prime
the viral entry protein for subsequent fusion steps. Attachment
factors, in contrast, are typically interchangeable, involve less
specific interactions, and serve primarily to localize the virus to its
receptor(s) and other cofactors necessary for fusion.
A recent study reported that human TIM1 (hTIM1), a protein
previously implicated as a receptor for the non-enveloped hepatitis
A virus [2–4], also functioned as a receptor for the enveloped
viruses Ebola (EBOV) and Marburg (MARV) [5]. This observa-
tion added hTIM1 to the long list of filovirus entry factors, which
include b1-integrins [6,7], the folic acid receptor alpha, which was
later disputed [8–10], the TAM receptors Axl, Mer and Tyro [11],
various C-type lectins [12–14] and the intracellular receptor
Niemann-Pick C1 (NPC1) [15–17]. hTIM1 was identified by
correlating gene expression patterns of 60 cancer cell lines with
their permissiveness to EBOV entry [5].
The TIM protein family is composed of three members in
humans (hTIM1, 3, and 4) and eight in mice (mTIM1-8) that are
implicated in the regulation of innate and adaptive immune
responses [18]. Based on expression, functional and structural data
hTIM1, 3, and 4 are considered direct orthologs of mTIM1, 3,
and 4, respectively [19,20]. The ectodomain of TIM proteins
includes an N-terminal variable immunoglobulin-like (IgV)
domain and a stalk-like mucin domain that varies in length and
O-glycosylation [18]. Importantly, the IgV domains of all hTIM
proteins contain a high-affinity binding site for PS, a phospholipid
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on the cytosolic side of the plasma membrane lipid bilayer, PS flips
to the outer leaflet upon the onset of apoptosis, where it acts as a
so-called ‘‘eat-me’’ signal for professional phagocytes (macrophag-
es and dendritic cells) as well as non-professional phagocytes (e.g.,
epithelial cells) [23–25]. Consistent with a PS receptor function,
one important role of TIM proteins is to initiate PS-mediated
engulfment of apoptotic cells and debris [21,22,26]. Although this
role may be more prominent for TIM3 and TIM4, which are
expressed on dendritic cell and macrophage sub-populations
[21,22,26,27], TIM1 is known to be expressed on various
epithelial cells [5,28], which can also assume phagocytic roles.
TIM1 and TIM3 are further expressed on subsets of activated T-
cells, where they act as costimulatory and coinhibitory molecules,
respectively [29–31].
Several recent findings suggest that negatively-charged phos-
pholipids like PS might play a role in mediating virus entry. PS was
shown to be exposed on the membranes of various enveloped
viruses, including Pichinde virus, vesicular stomatitis virus (VSV)
and the intracellular mature virion form of Vaccinia virus [32,33].
This is likely a common feature of most enveloped viruses, as virus-
infected cells were shown to overexpress PS on their plasma
membranes [32–34]. In addition, the entry of lentiviral pseudo-
viruses bearing the GPs of Sindbis (SINV), Ross River (RRV) and
Baculo virus was enhanced in a PS-dependent manner by the
TAM receptor tyrosine kinase Axl [35]. Axl has also been shown
to promote EBOV and MARV entry [11]. Finally, an antibody
targeting anionic phospholipids effectively rescued rodents from
lethal challenges by either Pichinde virus or mouse cytomegalo-
virus, demonstrating in vivo contribution of anionic phospholipids
to the infectivity of these viruses [33].
Because hTIM1 binds PS with high affinity [21] and various
viruses contain PS on their virion surfaces [32,33], we explored the
possibility that the reported hTIM1-mediated EBOV entry [5] is
PS dependent. Furthermore, using pseudoviruses, VLPs, and
infectious viruses bearing the entry proteins of 19 viruses from 7
different families, we investigated the generality of PS-receptor
usage and its underlying mechanisms. We observed that hTIM1
promoted infection by a range of viruses, including members of the
filovirus, flavivirus, alphavirus and New World arenavirus families,
and that this enhancement required the PS-binding activity of
hTIM1. We further demonstrated that additional PS receptors,
such as hTIM4 and hAxl enhanced the entry of most hTIM1-
using pseudoviruses, and that the efficiency of this enhancement
largely correlated with that observed with hTIM1. Finally, we
explore and discuss the molecular mechanisms that contribute to
the differential efficiency of viral PS receptor usage. Collectively
our data suggest that hTIM1 and related proteins function as
attachment factors for a full range of enveloped viruses.
Materials and Methods
Cells lines and plasmids
HEK293T (human embryonic kidney), Huh7 (human hepato-
carcinoma), 3T3(murine embryonicfibroblast)and MDCK (canine
kidney) cells were grown at 37uC in DMEM supplemented with
10% fetal bovine serum (FBS), 1 mM sodium pyruvate and 1%
penicillin/streptomycin (P/S). NPC1
2/2 and NPC1
2/2mNPC1
CHO cells (also referred to as M12 and wt8, respectively [36]) were
kept at 37uC inDMEM/F12with5%FBSand1%P/S. These cells
were gifts from Daniel S. Ory at Washington University School of
Medicine. C6/36 Aedes albopictus mosquito cells were maintained at
28uC in DMEM containing 10% FBS, 1 mM sodium pyruvate and
1% P/S.
Coding sequences of hTIM1, hTIM3 and hTIM4 (without
signal peptides) were PCR amplified from human T-cell or
macrophage cDNA libraries and cloned into the retroviral
expression vector pQCXIX (BD Biosciences) downstream of the
signal peptide of mouse angiotensin-converting enzyme 2 (ACE2)
and a myc-tag. Their sequences were deposited to the Genbank
under accession numbers JX049978, JX049979 and JX049980,
respectively. hAxl cDNA (clone 5205825, Invitrogen) was
purchased and similarly cloned into pQCXIX with an N-terminal
myc-tag. The PS-binding deficient variant of hTIM1 (AA-hTIM1)
was created by site-directed mutagenesis. It carries W112A and
F113A mutations based on the previously-described equivalent
mutations in other TIM proteins [19,21]. The stalk-truncated
D131-221 hTIM1 and D197-287 hTIM1 variants were obtained
using deletion mutagenesis.
The plasmids encoding N-terminally myc-tagged human ACE2
(hACE2) and civet cat ACE2 were previously described [37]. Also
previously described were the expression plasmids encoding the
entry glycoprotein precursors of Zaire EBOV (Mayinga) and Lake
Victoria MARV (Musoke), both lacking the mucin domains,
Amapari virus (AMAV, BeAn 7063), Tacaribe virus (TCRV),
Junı ´n virus (JUNV, MC2), Machupo virus (MACV, Carvallo),
Lassa fever virus (LASV, Josiah), lymphocytic choriomeningitis
virus (LCMV, Armstrong), Chikungunya virus (CHKV, 37997),
Eastern Equine Encephalitis virus (EEEV, FL91-4697), influenza
A virus (FLUAV, H7: Rostock, N1: Puerto Rico), VSV (Indiana),
SARS coronavirus (SARS-CoV; Tor2, GD and SZ) and West Nile
virus (WNV, lineage 1, NY99) [37–43]. The precursor of the
Oliveros virus (OLIV) entry protein was synthesized by GenScript
based on Genbank ID AAC54654.1 and was cloned into
pCAGGS.
Assessment of receptor expression
The expression of various receptors was assessed with mono-
clonal antibodies and detected using the Accuri C6 flow cytometer
(BD Biosciences). To measure endogenous hTIM1 expression,
cells were stained with mouse anti-hTIM1 antibody (clone 219211,
R&D Systems) or purified mouse Fc (mFc) as a negative control.
Author Summary
To infect cells, enveloped viruses typically utilize cellular
receptors, which mediate specific, high-affinity interactions
with the viral entry protein and prime the entry protein for
subsequent steps in the viral entry process. Viral entry is
also enhanced by attachment factors. Although less
specific than receptors, attachment factors can alter the
course of infection and thus severity of viral disease by
increasing the infection efficiency of specific target cells.
Here we observed that TIM proteins, a group of proteins
that promote phagocytosis of apoptotic cells, can dramat-
ically enhance the entry of a number of viruses, including
Ebola, West Nile and dengue viruses, whereas they have
little effect on the entry of other viruses. The inability of a
virus to use TIM proteins may be due to the presence of an
abundant, high-affinity receptor (Lassa fever virus), or
because the TIM proteins direct virions to a non-
productive internalization pathway (SARS coronavirus,
influenza A virus). Mechanistically, TIM proteins appear to
interact with enveloped viruses and apoptotic cells
similarly by binding phosphatidylserine residues exposed
on the viral and cellular membranes. Collectively our
studies show that TIM proteins are attachment factors that
can substantially improve the infection efficiency of a
number of pathogenic viruses.
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conjugated goat anti-mouse antibody (Jackson ImmunoResearch
Laboratories). To assess endogenous mouse TIM1 (mTIM1)
expression, cells were stained with anti-mTIM1-PE, a PE-
conjugated rat anti-mTIM1 antibody (clone RMT1-4, BioLegend)
or with anti-mIFNc-PE, a PE-conjugated rat anti-mouse interfer-
on gamma antibody (BioLegend) used as negative control. Cells
transfected or transduced to express exogenous receptors were
stained with various antibodies. While the antibody used to detect
wildtype (wt) hTIM1 and the AA-hTIM1 variant was the anti-
hTIM1 antibody described above, that used in the hTIM1 stalk
truncation experiment was anti-hTIM1 antibody 3D1, which
specifically recognizes the IgV head domain of hTIM1 [21].
Expression of N-terminally myc-tagged hAxl, hTIM3/4, hACE2
and civet cat ACE2 was assessed using anti-myc antibody 9E10.
MLV pseudovirus and WNV VLP entry assays
Pseudoviruses bearing various viral entry proteins were
produced in 293T cells as described [39] by calcium-phosphate
transfection of a retroviral vector pQCXIX (BD Biosciences)
encoding eGFP together with two other plasmids, separately
encoding a viral entry protein and the Moloney murine leukemia
virus (MLV) gag and pol. For FLUAV H7N1, an additional
plasmid encoding N1 neuraminidase (Puerto Rico) was co-
transfected [41]. Pseudovirus-containing culture supernatants were
harvested at 32–34 h post-transfection, filtered through a 0.45 mm
PES membrane, stored at 4uC, and used within 2 weeks. WNV
VLPs were produced and harvested in the same way after co-
transfecting a plasmid encoding the WNV structural proteins
(capsid and entry glycoproteins prM and E) and a WNV replicon
encoding the non-structural proteins NS1-5 and GFP [43].
For infection, cells were plated on poly-lysine-coated (293T) or
uncoated 48-well plates and incubated at 37uC with pseudovirus- or
VLP-containing supernatants diluted to yield comparable levels of
infection. In order for virus entry enhancement not to be limited by
virus titers, cells were generally incubated with virus supernatants
forlessthan 1 hour,unlessmentionedotherwise.Supernatantswere
then replaced with fresh medium, incubated for one (293T) or two
(3T3, Huh7 and NPC1
2/2) days to allow for eGFP reporter
expression and infection levels were assessed by measuring GFP
fluorescence with the Accuri C6 flow cytometer (BD Biosciences).
Independent experiments were performed with independent
pseudovirus and VLP preparations. In addition, all pseudoviruses
and VLPs used in a given experiment were produced in parallel.
Infection assays with replication-competent viruses
Lyophilized infectious TCRV (TRVL 11573), passaged in
suckling mice and Vero cells, as well as RRV (T-48) and SINV
(Ar-339), both passaged in suckling mice, were purchased from
ATCC, and resuspended in PBS according to the instruction.
Type 2 infectious dengue virus (DENV, New Guinea C) was
obtained by passaging in C6/36 Aedes albopictus mosquito cells.
Virus-containing culture supernatants were 0.45 mm-filtered,
stored at 280uC and virus titers determined using plaque assays
in baby hamster kidney cells as described [44]. Infectious FLUAV
(H1N1, A/PR/8/34) was propagated in MDCK cells [45],
0.45 mm-filtered and virus titers assessed as tissue culture infectious
dose 50 (TCID50) in cultured human macrophages using
CellTiter-Glo One solution (Promega). For infection, cells were
incubated for 1–6 h at 37uC with viruses serially diluted in
DMEM containing 10% FBS, washed and supplemented with
fresh medium. At indicated days post-infection, cells were
detached by trypsinization, washed, fixed with 1% formaldehyde
in PBS and permeabilized with 0.1% saponin in PBS containing
2% goat serum. Cells were then stained with immune ascitic fluids
(ATCC) for TCRV, RRV and SINV, anti-FLUAV antibody
C111 (Clontech), or anti-DENV antibody 2H2 (Millipore) [46]
followed by an Alexa 649- or PE-conjugated goat anti-mIgG
antibody (Jackson ImmunoResearch Laboratories) and analyzed
by flow cytometry.
Internalization assays
VP40-GFP VLPs were produced in 293T cells by co-
transfecting a pCAGGS-based plasmid encoding a previously
described GFP-fusion version of the EBOV VP40 matrix protein
[47], a gift from Christopher F. Basler at Mount Sinai School of
Medicine, with a plasmid encoding mucin-domain-deleted EBOV
GP at 3:1 ratio. To make VP40-GFP VLPs bearing no entry
protein, the VP40-GFP plasmid was similarly cotransfected with
an empty plasmid. VLP-containing culture supernatants were
harvested at 36 h post-transfection and cell debris removed by two
consecutive centrifugations at 900 g. The presence of fluorescent
filovirus-like particles in the supernatants was confirmed by
fluorescence microscopy.
MLVgag-GFP pseudovirions were produced similarly as
described for the non-fluorescent pseudoviruses, except that 25%
of the MLV gag-pol plasmid DNA was replaced with plasmid DNA
encoding a MLV gag-GFP fusion protein [48], a gift from Walther
Mothes at Yale University School of Medicine. Also, pQCXIX-
eGFP was replaced with the same vector encoding a non-
fluorescent protein. Virus supernatants were harvested at 34–36 h
post-transfection, 0.45 mm-filtered, purified by ultracentrifugation
(SW40Ti rotor, 70’000 g for 2 h at 10uC) and resuspended in a
small volume of DMEM containing 10% FBS.
To assess VLP/pseudovirion internalizaton, cells were incubated
for 2–6 h at 37uC with VP40-GFP VLPs, with MLVgag-GFP virions
normalized for MLV reverse-transcriptase (RT) activity or with mock
supernatants obtained from cells transfected with a plasmid expressing
eGFP alone. Uninternalized VLPs and virions were removed with two
1 min acid-washes (200 mM glycine, 150 mM NaCl, pH 3.0)
followed by trypsinization at 37uC for 15 min. Internalization of
VLPs or pseudovirions was assessed by flow cytometry.
Entry assays with VP40-b-lactamase VLPs and
macrophages
VLPs made with EBOV VP40 matrix proteins fused to b-
lactamase (Bla) and bearing EBOV GP, LASV GP or no GP were
produced as described above for VP40-GFP VLPs. The VP40-Bla
fusion construct was a gift from Paul Bates at University of
Pennsylvania [8]. Naive peritoneal macrophages were obtained
from wildtype BALB/cBYJ mice. Briefly, peritoneal cavity cells
were plated in 12-well plates at 10
6 per well and incubated for 1 h
at room temperature to let macrophages adhere. After removing
non-adherent cells by washing twice in PBS/2% FBS, macro-
phages were incubated overnight at 37uC in RPMI containing
10% FBS, 1% P/S and 50 mM b-mercaptoethanol and infected
the following day for 2 h at 37uC with VP40-Bla VLPs. Infected
cells were detached by scraping in trypsin/EDTA, washed and
loaded with the Bla substrate CCF2-AM, as previously described
[49]. The conversion of substrate by cytoplasmic esterases and Bla,
which reflects VP40-Bla VLP entry, was detected using the LSR II
flow cytometer (BD Biosciences).
Liposome blocking assays
1,2-diacyl-sn-glycero-3-phospho-L-serine (PS), 1,2-diacyl-sn-gly-
cero-3-phosphocholine (PC) and 1,2-diacyl-sn-glycero-3-phos-
phoethanolamine (PE) were purchased from Sigma and
TIM Proteins Enhance Infection of Multiple Viruses
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PC mixed with PS or PE at 1:1 molar ratios were dried under
argon and then in a SpeedVac for 1 h, followed by hydration in
PBS at a concentration of 1 mM total lipids. Liposomes were
made by sonicating these milky lipid suspensions to clarity, stored
at 4uC, and used within a week. For both entry and internalization
blocking assays, liposome preparations were diluted in the
appropriate medium containing 10% FBS and preincubated with
cells for 20–30 min at room temperature. Pseudoviruses or VLPs
were then added and culture plates shifted to 37uC for infection.
Independent experiments were performed with independent
liposome preparations.
Accession numbers
Relevant SwissProt accession numbers are Q96D42 (hTIM1),
Q8TDQ0 (hTIM3), Q96H15 (hTIM4), P30530 (hAxl), Q9BYF1
(hACE2), P02786 (hTfR1) and O15118 (NPC1).
Results
hTIM1 promotes pseudovirus and VLP entry mediated by
a range of viral entry proteins
We first tested the specificity of viral use of hTIM1 in two cell
lines that express little or no endogenous TIM1: human 293T and
murine 3T3 cells (Figs. 1A, B). Cells engineered to overexpress
hTIM1 or hACE2, a control receptor, were infected with a panel
of 14 MLV pseudoviruses bearing the GPs of the filoviruses EBOV
and MARV, the arenaviruses LASV, LCMV, AMAV, TCRV,
JUNV, MACV and OLIV, the alphaviruses CHKV and EEEV,
the orthomyxovirus FLUAV (H7N1), the rhabdovirus VSV or the
coronavirus SARS-CoV. In addition, cells were infected with
VLPs bearing the entry proteins of WNV, a member of the
flavivirus family. As shown in Figures 1C and S1, relative to
control cells, many pseudoviruses infected hTIM1-expressing
293T cells more efficiently. The entry of EBOV, AMAV, TCRV
and EEEV pseudoviruses as well as WNV VLPs was strongly
increased by hTIM1 (over 15 fold), that of CHKV considerably (8
fold) and that of MARV, JUNV, MACV and VSV moderately (2–
5 fold). The entry of the remaining pseudoviruses tested - LASV,
LCMV, OLIV, H7N1 and SARS-CoV - was increased by less
than two-fold, with LASV, H7N1 and SARS-CoV being the least
affected. Unlike in 293T cells, hTIM1 overexpression in 3T3 cells
had a less dramatic impact on viral entry (Figs. 1D and S1): Only
WNV VLPs showed a strong increase in entry in hTIM1-
expressing 3T3 cells relative to control 3T3 cells, while EBOV,
AMAV, TCRV, JUNV and MACV pseudoviruses showed a
moderate increase. In both experiments virus titers were not
limiting for non-hTIM1-using pseudoviruses, since longer infec-
tion times yielded much higher levels of entry in the control cells
(Figs. S1B, D). Together these data suggest that hTIM1 supports
the entry of a wide range of pseudoviruses, in particular those for
which no high-affinity cell surface receptor has been identified. In
addition, the effect of hTIM1 is dependent on the cellular
background in which the experiment is performed.
To further assess the role of TIM1, we tested the ability of an
anti-hTIM1 antibody to inhibit infection. As shown in Figure 1E
in TIM1-expressing 293T cells the mouse monoclonal anti-
hTIM1 antibody 3D1 [21] inhibited the entry of each pseudovirus
to the same extent as its entry had been enhanced by hTIM1.
Similar efficient inhibition was observed in Huh7 cells, a human
cell line with high endogenous hTIM1 expression (Figs. 1F,G):
Anti-hTIM1 antibody 3D1 inhibited the entry of EBOV, AMAV,
TCRV and EEEV pseudoviruses by over 70% at a 10 nM
concentration, indicating that hTIM1 serves as a major entry
factor for these viruses in Huh7 cells. JUNV pseudovirus entry was
also considerably inhibited (by 60%), suggesting that hTIM1 can
contribute to the entry of this virus in Huh7 cells, although JUNV
predominantly uses human transferrin receptor 1 (hTfR1) in other
cells [42,50,51]. In contrast, the other pseudoviruses tested were
only moderately affected by the presence of anti-hTIM1 3D1.
While results of these entry blocking experiments are overall
consistent with the gain-of-entry experiments in 293T cells
(Fig. 1C), there are a few exceptions. For instance, MARV and
CHKV pseudovirus entry was blocked less efficiently than
expected in Huh7 cells (Fig. 1G) and Huh7 cells were not
efficiently infected by WNV VLPs (data not shown).
hTIM1 enhances infection of various replication-
competent viruses
We then confirmed the role of hTIM1 in virus infection, using
replication-competent viruses. To circumvent the need for BSL3
or 4 laboratories, required for infectious MACV, JUNV, CHKV,
EEEV or WNV, we chose TCRV to represent the arenavirus
family, RRV and SINV to represent the alphavirus family and
DENV to represent the flavivirus family. In addition, FLUAV
H1N1 was used as a negative control. When hTIM1-293T cells
and the control hACE2-293T cells were infected with serially
diluted viruses, infection levels were markedly enhanced in
hTIM1-293T cells across the board, except for H1N1 (Fig. 2),
which is consistent with the pseudovirus entry data shown in
Figure 1. Of note, the magnitude of infection enhancement was
generally greater at low virus titers, implying that TIM1 may play
a more important role when virus titers are limiting, for example at
the initial phases of infection. This initial advantage conferred by
hTIM1 was further amplified during the first few cycles of
replication (Fig. S2). As a surrogate for replication-competent
EBOV we used EBOV VP40-based VLPs [8] bearing the wildtype
EBOV entry protein, and confirmed that hTIM1 efficiently
enhances their entry (data not shown).
hTIM1-mediated enhancement of pseudovirus and VLP
entry is PS dependent
hTIM1 is a receptor involved in the PS-mediated uptake of
apoptotic cells [21]. To test the hypothesis that hTIM1 may
broadly increase viral entry because it binds PS on viral
membranes rather than to specific viral glycoproteins, we
compared viral usage of a hTIM1 variant defective in binding
PS with that of wt hTIM1. The mutant variant, hereafter referred
to as AA-hTIM1, has two mutations in the PS-binding pocket that
are known to nearly abrogate PS binding [19,21]. Indeed, when
these receptors were overexpressed in 293T cells we found that
AA-hTIM1 was unable to enhance the entry of any pseudovirus
tested (Fig. 3A) despite efficient AA-hTIM1 expression (Fig. 3B).
This indicates that viral hTIM1 usage is PS-dependent.
To further assess the role of PS, we tested whether various
liposomes are able to block hTIM1-mediated viral entry (Fig. 3C).
Consistent with a PS-dependent mechanism, liposomes consisting
of 50% PS and 50% PC, but not those consisting of PC alone,
efficiently blocked the entry of all hTIM1-using pseudoviruses into
hTIM1-expressing 293T cells at 3 mM concentration. In contrast,
the entry of LASV and H7N1 pseudoviruses, whose entry is not
enhanced by hTIM1, were not affected by either liposomes.
Unexpectedly, PE-containing liposomes were also able to inhibit
hTIM1-medated viral entry (Fig. S3). This observation raises the
possibility that PE, another marker of apoptotic cells [52], which
shares structural similarities with PS but is not negatively charged
at physiological pH, may also play a role in viral hTIM1 usage.
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PLOS Pathogens | www.plospathogens.org 4 March 2013 | Volume 9 | Issue 3 | e1003232Figure 1. hTIM1 promotes infection mediated by a range of viral entry proteins. (A) Human 293T cells do not express TIM1. 293T and
control cells were stained with anti-hTIM1 antibody (red) or with mFc (black). (B) Murine 3T3 cells do not express TIM1. 3T3 and control cells were
stained with anti-mTIM1-PE antibody (red). Unstained cells (black) and cells stained with anti-mIFNc-PE (blue) served as negative controls. (C)
Exogenous hTIM1 increases the entry of various pseudoviruses in 293T cells. 293T cells were transfected with plasmids expressing hTIM1 or, as a
negative control, hACE2. 48 h later cells were infected with MLV pseudoviruses or WNV VLPs, both carrying the GFP reporter gene. The following day,
GFP expression was quantified by flow cytometry. Fold changes in entry were calculated by dividing mean fluorescence intensity observed in hTIM1-
expressing 293T cells by those in hACE2-expressing 293T cells. Figure shows mean+SD from three independent, duplicated experiments. (D) hTIM1
usage by pseudoviruses was similarly assessed in 3T3 cells transduced with hTIM1 or hACE2. (E) Entry inhibition by an anti-hTIM1 antibody parallels
hTIM1 use by pseudoviruses. 293T cells transduced with hACE2 (mock) or hTIM1 were preincubated for 30 min at room temperature with medium
alone (none), the anti-hTIM1 antibody 3D1 or mIgG, and infected with pseudoviruses overnight in the presence of the respective blocking agents.
Infection levels were normalized to those of untreated hTIM1-expressing cells. Figure shows mean+SD from two independent, duplicated
experiments. (F) Human Huh7 cells express high levels of TIM1. Huh7 cells and control cells were stained for TIM1 expression as in A. (G) An anti-
hTIM1 antibody inhibits entry of various pseudoviruses in Huh7 cells. Huh7 cells were incubated with antibodies and infected as in E. Infection levels
were assessed 48 h later as in C and normalized to those of untreated cells. Figure shows mean+SD from three independent, duplicated experiments.
doi:10.1371/journal.ppat.1003232.g001
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viral entry proteins
PS dependency of viral hTIM1 usage implies that virions lacking
any viral entry protein should also bind to and internalize into the
intracellular compartments of hTIM1-expressing cells. To test this we
took advantage of GFP-fused matrix proteins [47,48] that allow, when
incorporated into the virions, the detection of prefusion stages of viral
entry. As shown in Figures 4A and B, when 293T cells expressing
hTIM1, AA-hTIM1 or a control receptor were infected with EBOV
VP40-matrix-based VLPs (VP40-GFP VLPs), those bearing no GPs
were readily internalized by hTIM1, provided that the TIM1 PS-
binding domain was functional. Although EBOV GP-bearing VP40-
GFP VLPs appeared to be internalized more efficiently than those
lacking GP, this bias is most likely due to the fact that the latter are
released 3 to 5 times less efficiently from the producer cells [53,54].
Consistent with this explanation, when the internalization experiment
was repeated with RT-activity normalized MLVgag-GFP virions, we
obtained even higher internalization efficiencies for GP-free than
EBOV GP-bearing virions (Figs. 4C, D). Thus, results presented in
Figure 4 demonstrate that virions bind to and internalize via hTIM1
in a manner that is independent of specific viral entry proteins, but
instead is dependent on components of the viral membrane.
Differing mechanisms underlie the inability of hTIM1 to
promote infection of some pseudoviruses
We next tested whether the observation that GP-free MLVgag-
GFP virions are readily internalized by hTIM1 could be extended
to the same virions bearing the GPs of LASV, H7N1 and SARS-
CoV, which had been unaffected by hTIM1 expression in the entry
assays that rely on a post-fusion readout (Figs. 1 and S1). As shown
inFigure5A,theinternalizationofH7N1andSARSMLVgag-GFP
virions, normalized for RT-activity, considerably increased in the
presence of hTIM1, albeit less than that of EBOV and GP-free
virions. We cannot, however, exclude the possibility that the SARS
and H7N1 MLVgag-GFP virions that internalized via hTIM1, are
those carrying fewer entry proteins on the their surface. Nonethe-
less, this internalization was blocked by PS-containing liposomes,
but not by those consisting of only PC (Fig. 5B). These findings
indicate that hTIM1 promotes the PS-dependent internalization of
H7N1 and SARS-CoV virions without leading to productive
infection (compare with Figs. 1C, 6A and S1E). In contrast,
internalization of LASV MLVgag-GFP virions was only minimally
increased by hTIM1 (Fig. 5A) and was not blocked by PS-
containing liposomes (Fig. 5B), suggesting that the molecular
mechanism responsible for the lack of hTIM1-mediated entry for
LASV is distinct from those of H7N1 and SARS-CoV.
As suggested by Morizono et al. [35], PS receptor usage by
viruses may be influenced by their affinity for other cell surface
receptors. For instance, LASV internalization via alpha dystrogly-
can, its primary receptor, may be too efficient for PS receptors to
compete with. We tested this receptor-affinity hypothesis using the
GPs from various SARS-CoV isolates with differing affinities for
the same receptor. Tor2, isolated from the major SARS-CoV
outbreak, GD from a minor one, and SZ, from a reservoir species
civet cat, respectively show high, moderate and low affinity to
Figure 2. hTIM1 increases the infection of diverse replication-competent viruses. 293T cells transduced with hTIM1 or hACE2 (mock) were
infected for 1–6 h with infectious TCRV (A), RRV (B), SINV (C), H1N1 (D), or DENV (E) at increasing titers. Cells were trypsinized the following day (D and
E) or 2 days later (A, B and C), stained either with immune ascitic fluids (A, B and C) or with anti-FLUAV (D) or anti-DENV (E) antibodies. Figures show a
representative of the two duplicated experiments (A) or mean 6 SD of two independent, duplicated experiments (B–E). LD50: Lethal dose 50, as
determined in suckling mice at ATCC.
doi:10.1371/journal.ppat.1003232.g002
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hACE2, with or without hTIM1, were infected with pseudoviruses
bearing these GPs, infection levels reached by these three
pseudoviruses corresponded to their reported affinities to hACE2.
However, no TIM1-mediated entry increase was observed with
any of these SARS-CoV GPs, while the entry of the control
pseudovirus (TCRV) was substantially enhanced. These results
indicate that receptor affinity cannot explain the inability of
hTIM1 to promote infection in the case of SARS-CoV. To further
test the receptor-affinity hypothesis we assessed whether the
blocking of hTfR1, a high-affinity receptor for MACV [42], might
promote MACV’s TIM1 usage. However, as shown in Figure 6B,
the entry of MACV pseudovirus into TIM1-expressing 293T cells
was as strongly inhibited by the anti-hTfR1 antibody ch128.1 [51]
as in control cells. Thus, limiting the availability of the high affinity
receptor does not increase TIM1 usage.
Viral usage of the PS receptors hAxl and hTIM4 parallels
that of hTIM1
Since a number ofhuman PS receptorshavebeendescribed [25],
we sought to determine if PS receptors other than hTIM1 have a
similarly broad impact on viral entry. For example, hAxl was
recently shown to enhance the infection mediated by the entry
proteinsof SINV,RRVandBaculovirus ina PS-dependentmanner
by binding the serum proteins Gas-6 and Protein S, which in turn
bind PS displayed on these viruses’ membranes [35]. As shown in
Figure 7A, the infection of 293T cells expressing exogenous hAxl
with the panel of pseudoviruses and VLPs used in Figure 1 yielded a
pattern almost identical to that observed with hTIM1. One
exception, however, was that WNV VLP entry was not much
enhanced by hAxl, indicating that Gas-6 and Protein S from FBS
might bind PS differently compared to TIM proteins. We then
testedwhetherhTIM3and 4,alsoshowntobePSreceptors[21,22],
similarly enhance viral entry. Again, 293T cells expressing hTIM3,
hTIM4 or a control receptor were infected with various
pseudoviruses and WNV VLPs (Figs. 7B, C). While hTIM4
expression resulted in a pattern of entry enhancement similar to
that of hTIM1, hTIM3 showed only moderate support of TCRV
pseudovirus and WNV VLP entry. The mechanisms underlying
inefficient viral TIM3 usage seem to be complex (see Fig. S4 and
Supplementary Text S1). Collectively, these data indicate that
different PSreceptorstend toenhance infectionof the same viruses-
although not every virus uses every PS receptor - and suggest that
PS receptors other than TIMs and Axl are also likely to increase the
entry of a wide range of viruses using a common mechanism.
Contribution of PS receptors to viral entry in
physiological target cells
Experimental infections in animal models have shown that
macrophages are early targets for the replication of several viruses
Figure 3. hTIM1-mediated entry of pseudoviruses and VLPs is PS dependent. (A) A hTIM1 variant deficient in PS binding (AA-hTIM1) does
not support viral entry. 293T cells were transduced with hACE2 (mock), hTIM1 or AA-hTIM1, and infected 2 days later with the indicated
pseudoviruses or WNV VLPs. Entry was determined by GFP-expression measured by flow cytometry. Figure depicts representative results from one of
three independent, duplicated experiments. M.f.i.: mean fluorescent intensity. (B) In parallel with the infection in A, expression levels of hTIM1 and
AA-hTIM1 were assessed as in Figure 1A. (C) hTIM1-mediated virus entry enhancement is efficiently blocked by PS-containing liposomes. 293T cells
transduced with hACE2 (mock) or hTIM1 were preincubated for 20 min at room temperature with medium alone (none) or with liposomes consisting
of either 50% PS and 50% PC (PS/PC) or PC alone (PC). Pseudoviruses or WNV VLPs were then added for a 30 min infection at 37uC, after which
unbound liposomes and viruses were washed away and cells supplemented with fresh medium. Entry was quantified as in A and normalized to those
of untreated hTIM1-expressing cells. Figure shows mean+SD of three independent, duplicated experiments.
doi:10.1371/journal.ppat.1003232.g003
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viral entry in mouse peritoneal macrophages, which are known to
express TIM4 [21] and other PS receptors. To be able to detect
viral entry instantaneously, we used VLPs consisting of EBOV
VP40 matrix proteins fused to b-lactamase (VP40-Bla VLPs [8])
for infection. As shown in Figure 7D, the entry of VP40-Bla VLPs
bearing EBOV GP was inhibited by 45% in the presence of PS-
containing liposomes at 10 mM, reflecting as expected that other
host cell molecules also play a role in virus infection. In contrast,
the entry of the same VLPs bearing LASV GP was only little
inhibited (by 8%). The blocking effect was specific for PS, as
liposomes consisting of only PC did not inhibit either VLPs. These
data are consistent with the notion that PS receptors can help
potentiate viral infection in macrophages.
hTIM1-mediated EBOV pseudovirus entry is dependent
on NPC1
EBOV and MARV entry was recently shown to critically
depend on NPC1, a cholesterol-transporting protein located in the
endo/lysosomal compartment [15–17]. To test whether hTIM1
usage by EBOV and MARV is dependent on NPC1, we used
NPC1-null CHO cells (NPC1
2/2), as well as NPC1-null CHO
cells engineered to overexpress mouse NPC1 (NPC1
2/2mNPC1),
which supports EBVO entry [36]. As expected based on our
earlier results (Fig. 1), EBOV pseudovirus entry, and to a lesser
extent MARV entry, in NPC1
2/2mNPC1 cells was increased in
the presence of hTIM1 (right panels of Figs. 8A, B). In contrast,
the previously reported non-permissiveness of NPC1
2/2 cells to
EBOV and MARV [15] was not circumvented by hTIM1
overexpression (left panels of Figs. 8A, B). These data indicate
that hTIM1 expression cannot overcome NPC1 dependence,
confirm the role of NPC1 as a filovirus entry factor and suggest
that hTIM1 itself may best be regarded as an attachment factor.
Discussion
Our results, summarized in Figure 9, demonstrate that hTIM1
is an efficient attachment factor for a range of enveloped viruses,
and imply that hTIM1 promotes infection by associating with PS
on the virions. PS dependency of TIM1 is supported by several
independent lines of evidence. First, all pseudoviruses capable of
using hTIM1 can also be enhanced by at least one other PS
receptor, e.g., hTIM4 or hAxl (Fig. 7). Second, a functional,
hTIM1 PS-binding domain was an absolute prerequisite for viral
hTIM1 usage (Fig. 3). Finally, the interaction between hTIM1 and
GP-free virions was sufficient to elicit attachment and internali-
zation, and this internalization was blocked by PS-containing
liposomes (Figs. 4 and 5).
Our data are noteworthy and surprising in a few respects. First,
the finding that the entry efficiency of a large number of viruses
can be enhanced by TIM1 or related receptors suggests that PS
receptors may play a more prominent role in viral entry than
Figure 4. Viral entry proteins are not required for hTim1-mediated internalization into cells. (A) VP40-GFP VLPs lacking any viral entry
protein are bound and internalized by hTIM1. 293T cells transduced with hACE2 (mock), hTIM1 or AA-hTIM1 were incubated for 6 h with VP40-GFP
VLPs bearing EBOV GP or no GP. Being inherently fluorescent, these VLPs can be detected independently of whether they undergo fusion, in contrast
to the pseudoviruses and VLPs used in previous figures. The supernatant of cells expressing only GFP (mock supernatant) served as negative control.
Uninternalized VLPs were detached by acid-stripping and extensive trypsinization, after which internalized VLPs were detected by flow cytometry.
Figure depicts results representative of three independent experiments performed in duplicates. (B) In parallel with the infection in A, expression
levels of hTIM1 and AA-hTIM1 were assessed as in Figure 1A. (C) MLVgag-GFP pseudovirions lacking viral GPs are bound and internalized at least as
efficiently as those bearing EBOV GP. 293T cells transduced with hACE2 (mock), hTIM1 or AA-hTIM1 were infected for 6 h with purified and RT-activity
normalized MLVgag-GFP pseudovirions. The supernatant of cells expressing only GFP (mock supernatant) served as negative control. Cell surface-
bound pseudovirions were detached by acid-stripping and extensive trypsinization, after which internalized virions were detected by flow cytometry.
Data shown are representative of three independent experiments performed in duplicates. (D) In parallel with the infection in C, expression levels of
hTIM1 and AA-hTIM1 were assessed as in Figure 1A.
doi:10.1371/journal.ppat.1003232.g004
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structural studies reporting that the membranes of flavi- and
alphaviruses are occluded by tightly-arranged viral glycoproteins.
However, flavivirus virions often incorporate immature glycopro-
teins [57], which could lead to gaps in the glycoprotein coat
through which PS becomes accessible. Our findings are consistent
Figure 5. TIM1-mediated pseudovirus internalization does not always coincide with TIM1-mediated entry enhancement. (A) Some
pseudoviruses that do not use hTIM1 for productive entry are still efficiently internalized by hTIM1. Mock- or hTIM1-transduced 293T cells were
infected for 2 h with purified, RT-activity normalized MLVgag-GFP pseudovirions. Uninternalized virions were detached by acid-stripping and
extensive trypsinization, after which internalized virions were detected by flow cytometry. Data shown are representative of two independent
experiments performed in duplicates. (B) hTIM1-mediated pseudovirus internalization is blocked by PS-containing liposomes. Mock- or hTIM1-
transduced 293T cells were preincubated for 20 min at room temperature with medium alone (none), or with liposomes consisting of either 50% PS
and 50% PC (PS/PC) or PC alone (PC). MLVgag-GFP pseudovirions, prepared as in A, were then added for a 2 h infection at 37uC, after which bound
virions were detached and internalized virions were detected as in A. Figure shows mean+SD of two independent, duplicated experiments.
doi:10.1371/journal.ppat.1003232.g005
Figure 6. Receptor affinity does not determine the use of hTIM1 by SARS-CoV and MACV pseudoviruses. (A) 293T cells were
transduced with empty vector (mock) or hACE2, the receptor for SARS-CoV, followed by a second transduction with empty vector or hTIM1. These
cells expressing hACE2 and/or hTIM1 were then infected with pseudoviruses carrying the GFP-reporter gene and the entry glycoprotein of the
indicated SARS-CoV isolates that use hACE2 with varying efficiency [37]. Comparable titers of these pseudoviruses were confirmed by infecting cells
expressing civet cat ACE2, which is efficiently used by all SARS-CoV isolates [37]. Infection levels were assessed the following day by measuring GFP
expression. Shown are representative results of one of three experiments performed in duplicates. (B) 293T cells transduced with hTIM1 or hACE2
(mock) were preincubated for 20 min at room temperature with increasing concentrations of anti-hTfR1 antibody ch128.1. MACV or LASV
pseudoviruses were then added for a 1 h infection at 37uC, after which cells were washed and supplemented with fresh antibody-containing
medium. Infection levels were assessed the following day as in A. Figure shows mean 6 SD from two independent, duplicated experiments.
doi:10.1371/journal.ppat.1003232.g006
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entry [58]. Second, as described below, the importance of PS
receptors in viral entry is underscored by the fact that severalviruses
are known to initiate infections in PS receptor-rich cells. Finally,
because the exposure of PS on virions is likely a common feature of
enveloped viruses [33], it is perhaps most surprising that the entry of
a number of viruses remains unaffected by TIM1 expression.
There are several plausible explanations for why not every PS
receptor supports the entry of every enveloped virus (Fig. 9). First,
PS receptor usage could be affected by the endocytic routes of bona
fide virus receptors. For example, the six arenaviruses used in
Figure 1C can be divided into three groups with respect to TIM1
use: LASV and LCMV, which use alpha-dystroglycan as their
cellular receptor [59] only weakly utilize TIM1; MACV and
JUNV whose receptor is TfR1 [42,50] use TIM1 with moderate
efficiency; and TCRV and AMAV, which lack a known human
receptor, utilize TIM1 with exceptionally high efficiency. For
TIM1 to enhance infection, the endocytic pathways of TIM1-
mediated internalization probably need to coincide with those of
the primary receptors of these viruses. The finding that hTIM1 use
by MACV is dependent on the presence of hTfR1 (Fig. 6B) is
consistent with this hypothesis. However, the same explanation
may not fully describe the clear differences in TIM1 usage among
EBOV, MARV, H7N1 and SARS-CoV (Figs. 1 and S1), all of
which need access to late endosomes/lysosomes for productive
infection. A second possibility, suggested by Morizono and
colleagues for hAxl, is that high-affinity receptors may render
hTIM1 use ineffective for some viruses [35]. Although appealing,
this receptor-affinity hypothesis cannot explain the absence of
TIM1 usage by the SARS-CoV SZ isolate with low affinity to
hACE2 or the finding that MACV’s hTIM1 use was not enhanced
upon blockage of the hTfR1-mediated entry route (Fig. 6). A final
possibility is that steric hinderance by individual viral entry
proteins may affect TIM1-mediated enhancement. Specifically,
long or densely packed entry proteins, which are usually covered
with glycans, may prevent PS receptors from reaching PS on the
viral membrane. Consistent with this hypothesis, truncated
hTIM1 variants and hTIM3, which has a much shorter mucin
stalk than hTIM1, were used less efficiently than wt hTIM1 by
several pseudoviruses (Figs. 7 and S4).
The efficiency with which viruses utilize PS receptors also
appears to be dependent on the cellular background. For example,
Figure 7. Other PS-binding receptors similarly promote entry of hTIM1-using pseudoviruses. (A) Exogenous hAxl usage in 293T cells.
293T cells were transfected with hAxl or hACE2, infected with pseudoviruses or WNV VLPs, both carrying a GFP reporter gene, and infection levels
were assessed the following day by measuring GFP expression by flow cytometry. Fold changes in entry were calculated by dividing mean
fluorescence intensity observed in hAxl-expressing 293T by those of hACE2-expressing 293T cells. Figure shows mean+SD from three independent,
duplicated experiments. Note that the entry of WNV VLPs is only little increased by hAxl. (B) Exogenous hTIM3 and hTIM4 use in 293T cells. 293T cells
were transfected with plasmids expressing hTIM3, hTIM4 or hACE2, infected with the indicated pseudoviruses or WNV VLPs and infection levels were
assessed as in A. Shown are mean+SD from three independent experiments. Note that, unlike hTIM1 and hTIM4, hTIM3 only weakly enhanced
infection of TCRV pseudoviruses and WNV VLPs. (C) Both hTIM3 and hTim4 are expressed efficiently. The same cells as in B were stained with anti-myc
tag antibody. Figure shows representative results of one of three independent experiments. (D) PS receptors contribute to EBOV VLP entry in
macrophages. Mouse peritoneal macrophages plated the previous day were preincubated for 30 min at room temperature with medium alone
(none) or with liposomes consisting of 50% PS and 50% PC (PS/PC) or PC alone (PC). VP40-Bla VLPs bearing the entry proteins of EBOV, LASV, or no GP
(negative control) were then added for a 2 h infection at 37uC, after which cells were detached, washed, loaded with the Bla substrate CCF2-AM,
washed again and analyzed by flow cytometry. Figure is representative of two experiments performed in duplicates.
doi:10.1371/journal.ppat.1003232.g007
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entry in 3T3 compared to 293T cells (Fig. 1). This difference may
be due to cell-specific expression of various endogenous PS
receptors. Consistent with this explanation, 3T3 cells express Axl
[60,61], while 293T cells do not [11,35]. In addition, WNV VLPs,
which do not efficiently utilize Axl (Fig. 7A), were the only VLP/
pseudovirus showing strong TIM1-mediated entry enhancement
in 3T3 cells (Fig. 1D). This example emphasizes that results
obtained with specific cell lines need to be generalized with
caution.
One important question concerning viral PS receptor usage is
whether PS receptors are sufficient for productive infection or
whether virus-specific receptors are still required. We showed for
several pseudoviruses that TIM1-mediated entry depended on the
availability of their cellular receptors (Figs. 6B and 8), indicating
that TIM1 functions solely as an attachment factor. For instance,
TIM1 was unable to enhance the infection of EBOV and MARV
pseudoviruses in the absence of the intracellular filovirus entry
factor NPC1 (Fig. 8). Also, blocking the accessibility of MACV
pseudovirus to its receptor hTfR1 lowered MACV TIM1 usage
(Fig. 6B). On the other hand, some viruses were reported to fuse
with receptor-free liposomes at low pH [62–64], raising the
possibility that in a few specific cases PS receptor-mediated
internalization may be sufficient for productive infection. Never-
theless, studies using liposomes that are unnaturally enriched with
specific lipid components may not accurately represent physiolog-
ical conditions.
PS receptors form a complementary, widely expressed
network of receptors that is characterized by functional rather
than structural conservation. These particular features of PS
receptors likely contribute to their exploitation by viruses as
attachment factors. Notably, several PS receptors, including
TIM4, are highly expressed on mammalian macrophages and
dendritic cells. These cells play critical roles in the initial stages
of infection of filoviruses and flaviviruses in particular [55,56,65],
and PS receptors may thus play correspondingly important roles
in establishing these infections. PS receptors may be more
important still for viruses like DENV, WNV, EEEV and CHKV,
which are borne by insect vectors. The role of PS as apoptotic
marker is conserved in insects [66], and compared to mamma-
lian cells the membranes of insect cells are generally enriched
with PE [67,68], which binds several PS receptors. Thus
mosquito-delivered virions may especially benefit from PS
receptor-mediated enhancement of infection.
In conclusion, our results indicate that hTIM1, hTIM4, hAxl
and potentially other PS-binding receptors can enhance the entry
of a number of highly divergent viruses. As demonstrated for
hTIM1, the enhancement conferred by all of these receptors is
likely PS dependent and does not require any viral entry protein.
Accordingly, these proteins cannot properly be described as viral
receptors, although the nature of the viral entry protein clearly
impacts the relevance of PS receptors to infection. In some cases,
PS receptors may play critical roles in establishing or maintaining
an in vivo infection, which could affect disease severity. Thus our
results support the proposal of Soares et al., demonstrated for
Pichinde virus and mouse cytomegalovirus [33], that therapeutic
strategies targeting PS and other anionic phospholipids may be
broadly effective against a wide range of viruses.
Figure 8. hTIM1-mediated EBOV and MARV entry is dependent on the presence of the intracellular receptor NPC1. CHO cells lacking
NPC1 (NPC1
2/2) and the same cells stably expressing mouse NPC1 (NPC
2/2mNPC1) were mock transduced or transduced to express hTIM1. (A) Cells
were assessed for hTIM1 expression levels using anti-hTIM1 antibody as in Figure 1A. (B) Cells were infected for 0.5–1 h with EBOV or MARV
pseudoviruses, which were concentrated 3–5 fold by ultracentrifugation, or with unconcentrated TCRV or H7N1 pseudoviruses as positive and
negative controls for TIM1 use. Infection levels for all viruses were assessed 2 days after infection by measuring GFP expression. Regardless of hTIM1
expression, NPC1
2/2 cells showed no GFP positive cells with either EBOV or MARV infection when inspected by fluorescence microscopy. Figure
depicts representative results of one of three experiments performed in duplicates.
doi:10.1371/journal.ppat.1003232.g008
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Figure S1 Supplemental studies of exogenous hTIM1
use in 293T and 3T3 cells. (A & C) hTIM1 use in 293T or 3T3
cells represented using % positive cells. In parallel with the mean
fluorescence intensity (m.f.i.), infection levels were assessed using
the percentage of GFP positive cells. Note that these graphs also
show data for MLV pseudoviruses bearing no viral entry
glycoproteins (no GP). Figure shows representative results of one
of three experiments performed in duplicates. (B & D) In parallel
with the short infection times used for assessing hTIM1 usage in
Figures 1C and D, 293T and 3T3 cells were subject to a longer
infection (4 h for 293T and 12 h for 3T3) to assess whether
pseudovirus titers might be limiting, especially for viruses showing
low or no TIM1 use. Figure shows representative results from one
of three experiments performed in duplicates. (E & F) SARS
(Tor2) pseudovirus entry is not enhanced by exogenous hTIM1 in
293T or 3T3 cells. SARS (Tor2) pseudovirus entry into 293T cells
expressing the empty vector (mock), hTIM1 or the SARS-CoV
receptor hACE2 was assessed as in Figure 1C. Since 293T or 3T3
cells are completely refractory to SARS pseudovirus entry in the
absence of exogenous hACE2, both positive and negative control
cells were used, making it necessary to separate this data from
Figs. 1C and D. Figure shows mean+SD of three independent,
duplicated experiments.
(EPS)
Figure S2 Supplemental studies of hTIM1 use by
infectious viruses. 293T cells transduced with hTIM1 or
hACE2 were incubated for 6 h with infectious TCRV (A), RRV
(B) or SINV (C), or for 1 h with infectious DENV (D), washed, and
further incubated for one, two or three consecutive days. At the
indicated days, cells were trypsinized, stained either with immune
ascitic fluids (A–C) or with anti-DENV antibody (D), and infection
levels were measured by flow cytometry. Figures show a
representative of two duplicated experiments (A) or mean 6 SD
of two duplicated experiments (B–D).
(EPS)
Figure S3 PE-containing liposomes also block hTIM1-
mediated enhancement of viral entry. 293T cells trans-
duced with hACE2 (mock) or hTIM1 were preincubated for
20 min at room temperature with medium alone (none) or with
liposomes consisting of either 50% PE and 50% PC (PE/PC) or
PC alone (PC). Pseudoviruses or WNV VLPs were then added for
a 30 min infection at 37uC, after which unbound liposomes and
viruses were washed off and cells supplemented with fresh
Figure 9. A model of viral PS receptor usage. Human TIM proteins (TIMs) and other PS-binding receptors efficiently, but nonspecifically,
promote internalization of various enveloped viruses. The TAM receptors Axl, Mer and Tyro (TAMs) similarly bind and internalize many viruses, albeit
indirectly via the PS-binding bridging proteins Gas6 and/or Protein S (Prot S) in serum [35]. For most viruses PS-dependent internalization results in a
moderate to strong increase of productive infection. Note that the degree of enhancement will depend on the cellular background in which
experiments are performed. However, in the case of other viruses, PS receptor-mediated internalization may lead to a compartment that is not
productive for infection. In addition, there is a third class of viruses, which is not efficiently bound and/or internalized by PS receptors. The indicated
viruses were categorized based on hTIM1 usage and internalization results obtained with pseudoviruses and VLPs (black) or replication-competent
viruses (blue). Note, however, that the consequences or efficiency of internalization can vary depending on the PS receptors and their expression
levels.
doi:10.1371/journal.ppat.1003232.g009
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measuring GFP expression, and normalized to those of untreated
hTIM1-expressing cells. Figure shows mean+SD from three
independent, duplicated experiments.
(EPS)
Figure S4 Contribution of stalk length and O-glycans of
hTIMs to virus entry. (A) Schematic representation of the three
human TIM proteins and stalk-truncated hTIM1 variants used in
B–C. hTIM3 differs from the other TIMs because its stalk is
shorter and because it has a dramatically reduced number of O-
glycans [18]. The two truncation variants of hTIM1, D131-221
and D197-287 hTIM1, were made to resemble hTIM3 in stalk
length and number of O-glycosylation sites. (B) Expression levels of
stalk-truncated and wt hTIM1 are comparable. 293T cells were
transfected with plasmids expressing hACE2 (mock), D131-221
hTIM1, D197-287 hTIM1 or wt hTIM1. 48 h later cells were
stained with the anti-hTIM1 antibody 3D1, which binds the IgV
head domain of hTIM1 [21]. Figure shows representative results
of one of three experiments performed in duplicates. (C) Usage of
stalk-truncated hTIM1 variants in 293T cells. The same cells as in
B were infected with the indicated pseudoviruses carrying a GFP
reporter gene. Infection levels were assessed the following day by
flow cytometry and normalized to those of wt hTIM1-expressing
cells. Figure shows representative results of one of three
experiments performed in duplicates.
(EPS)
Text S1 Molecular causes underlying the inefficient
viral usage of TIM3.
(DOC)
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